Cerebrolysin is also known as FPF-1070. It is a mixture of low-molecular-weight peptides and amino acids derived from pig brain tissue. Cerebrolysin is a neurotrophic drug that promotes neurogenesis, synaptogenesis, and neuroprotection. Cerebrolysin is used to treat a variety of neurological disorders, including stroke, traumatic brain injury (TBI), Alzheimer’s disease, and dementia.
Cerebrolysin was developed in the 1960s by Dr. Eugeniusz Klein at the Institute of Pharmacology of the Polish Academy of Sciences in Kraków, Poland. Klein was interested in developing a drug that could promote the regeneration of damaged brain tissue. He experimented with a variety of different substances, but eventually settled on a mixture of low-molecular-weight peptides and amino acids derived from pig brain tissue.
Klein’s early experiments with Cerebrolysin were promising. He found that the drug could promote the growth of new neurons and synapses in animal models of brain injury. He also found that Cerebrolysin could improve neurological function in animals with a variety of neurological disorders, such as stroke, spinal cord injury, and Alzheimer’s disease.
In the 1970s, Klein began clinical trials of Cerebrolysin in humans. The results of these trials were positive. Cerebrolysin was shown to be safe and effective in the treatment of a variety of neurological disorders, including stroke, TBI, Alzheimer’s disease, and dementia.
Cerebrolysin is now approved for use in over 50 countries around the world. It is one of the most widely used drugs for the treatment of neurological disorders.
Other names for Cerebrolysin
Cerebrolysin is also known by the following names:
- FPF-1070
- Cerebrolysin Peptide
- Cerebrolysin Solution
- Cerebrolysin Ampoules
- Cerebrolysin Injection
How is Cerebrolysin administered?
Cerebrolysin is administered intravenously (IV) or intramuscularly (IM). The dosage and duration of treatment vary depending on the condition being treated. For example, the typical dosage for stroke is 10-30 ml IV daily for 10-20 days.
What are the side effects of Cerebrolysin?
Cerebrolysin is generally well-tolerated, with few side effects. The most common side effects are headache, nausea, and dizziness. In rare cases, more serious side effects, such as allergic reactions and seizures, have been reported.
Who should not use Cerebrolysin?
Cerebrolysin should not be used by people who are allergic to pig brain tissue or any of the other ingredients in Cerebrolysin. Cerebrolysin should also not be used by people with severe kidney disease or liver disease.
Cerebrolysin is a unique drug with a wide range of potential applications. It is used to treat a variety of neurological disorders and to improve cognitive function in healthy people. Cerebrolysin is generally well-tolerated, with few side effects.
If you are considering using Cerebrolysin, talk to your doctor. They can help you weigh the risks and benefits and determine if Cerebrolysin is right for you.
